Lillys Oral GLP-1, Orforglipron, Delivered Superior Blood Sugar Control and Weight Loss Compared to Oral Semaglutide in Head-to-Head Type 2 Diabetes Trial Published in The Lancet
Heart rate is also phenotype-coupled: near zero at 1 mg in the obese trial cohort, but +10 bpm or more at the same 1 mg in a leaner body from Phase 1
However, a more recent study in the journal Obesity found that a 2.4 mg dose of semaglutide still causes meaningful weight loss in people with obesity who are taking antidepressants
Magnesium: Required for the synthesis of glutathione within the cells
Ipamorelin supports tissue repair, stronger bones, and relief from chronic aches
Nutrition can rebuild the engine, but pacing ensures you don't burn it out again